<DOC>
	<DOCNO>NCT00713817</DOCNO>
	<brief_summary>The purpose study assess maintenance effect long-term treatment Sativex® subject neuropathic pain .</brief_summary>
	<brief_title>A Study Determine Maintenance Effect After Long-term Treatment Sativex® Subjects With Neuropathic Pain</brief_title>
	<detailed_description>A five week randomised-withdrawal phase ( Part B ) subset subject take part 38 week , multicentre , open label ( Part A ) follow-on study evaluate , maintenance effect , development tolerance exposure , safety , Sativex® treatment subject neuropathic pain . Subjects return centre end treatment visit week 38 Part A ( Visit 5 , Day 266 ) , follow Visits 5b ( week 39 ) , 5c ( week 43 ) end study visit take place 28 day Visit 5c withdrawal study .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<criteria>Had participate GWCL0404 , currently ongoing study ( i.e . still receive GW100002 treatment ) complete study Visit 5 Had comply study requirement todate , include completion diary card Had show tolerability study medication study Ability ( investigator opinion ) willingness comply study requirement , include completion diary card study questionnaire Had experience currently experience adverse event untoward medical occurrence , opinion investigator , would prevent safely participate phase study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Pain</keyword>
	<keyword>Peripheral Neuropathy</keyword>
</DOC>